Toward Optimizing Short-Acting Beta-Blockers in Septic Shock

Department of Medicine, The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA. Dr. Bosch's institution received funding from the National Institutes of Health, the American Heart Association, and the Department of Defense. He disclosed off-label use of landiolol and esmolol.